PerspectivePUBLIC HEALTH

Multicriteria decision analysis and core values for enhancing vaccine-related decision-making

See allHide authors and affiliations

Science Translational Medicine  29 Jun 2016:
Vol. 8, Issue 345, pp. 345ps14
DOI: 10.1126/scitranslmed.aaf0756

Figures

  • Fig. 1. Under-age-5 mortality.

    Comparison of under-age-5 mortality in Sweden and China between 1751 and 2008. Credit: Adapted from (8) with permission.

    CREDIT: H. MCDONALD/SCIENCE TRANSLATIONAL MEDICINE
  • Fig. 2. Core values and multicriteria decision-making for vaccine development and deployment.

    Additional attributes to be considered for other stakeholders or conditions (developed countries, low- and middle-income countries, emerging infections, and manufacturers) are shown surrounding the core values.

    CREDIT: H. MCDONALD/SCIENCE TRANSLATIONAL MEDICINE

Tables

  • Table 1. Narrow and comprehensive approaches to the economic evaluation of vaccines (14).
    PerspectiveBenefit categories
    Narrow and comprehensiveHealth care cost savings
    Narrow and comprehensiveCare-related productivity gains
    ComprehensiveOutcome-related productivity gains
    ComprehensiveBehavior-related productivity gains
    ComprehensiveCommunity externalities
    ComprehensiveUtilitarian value of health gains

Navigate This Article